Virios Therapeutics (VIRI) Set to Announce Quarterly Earnings on Thursday

Virios Therapeutics (NASDAQ:VIRI) is set to release its earnings data before the market opens on Thursday, May 9th. Analysts expect Virios Therapeutics to post earnings of ($0.08) per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Virios Therapeutics (NASDAQ:VIRI) last issued its earnings results on Thursday, February 29th. The company reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.09) by $0.03. On average, analysts expect Virios Therapeutics to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Virios Therapeutics Stock Performance

Shares of NASDAQ VIRI traded up $0.03 during midday trading on Tuesday, hitting $0.44. 21,167 shares of the company’s stock were exchanged, compared to its average volume of 320,495. The company’s 50 day moving average price is $0.42 and its 200 day moving average price is $0.52. Virios Therapeutics has a 12 month low of $0.28 and a 12 month high of $2.42.

Virios Therapeutics Company Profile

Virios Therapeutics, Inc, a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia.